[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.34 número5
Has 10000 "Rev. Bras. Hematol. Hemoter. vol.34 número5" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.34 número5".
Rev. Bras. Hematol. Hemoter. vol.34 número5
... From the observation that a substantial number of positions for residents in hematology and transfusion medicine remain unilled and aiming to improve medical residency progra[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número5
... CML-CP patients who converted into CML-AP had signiicantly higher (p-value < 0.05) leukocyte SOD activity than CML-CP patients who did not convert into CML-AP (Table 2)... 395 Short[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número5
... there has been little development of nutritional care protocols for patients with cancer as to optimal Background: The development of nutrition care programs for patients undergoing hematopoietic stem cell ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número5
... The quantiication of the amount of minimal residual disease (MRD) in the bone marrow (BM) of patients with acute lymphoblastic leukemia (ALL) at several points of the treatment of the [r] ... See full document
1
Rev. Bras. Hematol. Hemoter. vol.34 número5
... 3. Oliveira F. Saúde da população negra: Brasil ano 2001[Internet]. Brasília: Organização Pan Americana da Saúde; 2003. [cited 2012 Jul 27]. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/0081.pdf 4. Naoum PC. ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número5
... Other scenarios in which voriconazole is frequently used include primary prophylaxis of high risk patients (allogeneic HSCT or even AML patients in induction remission), secondary prop[r] ... See full document
9
Rev. Bras. Hematol. Hemoter. vol.34 número5
... Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis amo[r] ... See full document
16
Rev. Bras. Hematol. Hemoter. vol.34 número5
... The irst cycle of treatment was modiied in patients with severe clinical events at diagnosis, such as a high tumor burden associated with pleural and peritoneal effusions, tumor lysis[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número5
... Measurement of the hemoglobin (g/dL) and ferritin (ng/dL) levels were also evaluated according to gender and compared between the Anemic and Non-anemic Groups using the Ma[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número5
... Evaluation instruments included the 2-minute walking test to evaluate gait performance with assessment of the oxygen saturation, heart rate and Borg Scale before and after the test; gr[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.34 número5
... Overall, genetic guidance and laboratory screening of the family turned out to be effective educational and preventive measures as the majority of patients improved their level of know[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número5
... The group of patients consisted of 34 women (53.1%) and 30 men (46.9%), with ages that ranged from 20 to 80 years and with a median age of 44 years. The patients were stratiied into two groups according to ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.34 número5
... 6. KC Cunha, MC Oliveira, AC Gomes, LP de Castro, MB Viana. Clinical course and prognostic factors of children with Burkitt’s lymphoma in a developing country: the experience of a single centre in Brazil. Rev ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número5
... Moreover, it creates an opportunity to conduct larger studies to evaluate risk factors for poor functional performance in transplant recipients in Brazil and to design future intervent[r] ... See full document
1
Rev. Bras. Hematol. Hemoter. vol.34 número5
... In this issue, an article entitled “Clinical impact of systematic nutritional care in adults submitted to allogeneic hematopoietic stem cell transplantation” attempts to demonstrate the[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número5
... Therefore, because the translated BCR-ABL product is expressed only in leukemic cells and not in normal cells, the chimeric peptides encompassing the e13a2, e14a2 or e1a2 breakpoints m[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número5
... Given the indings in this and other studies, what measures can blood collectors pursue to address iron depletion? There is no single answer, but several approaches should be considered[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número6
... 4. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, Chapman CE, Davison K, Gerrard R, Gray A, Knowles S, Love EM, Milkins C, McClelland DB, Norfolk DR, Soldan K, Taylor C, Revill J, Williamson LM, Cohen ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número6
... analyzed the incidence and the risk factors for central nervous system (CNS) relapse in children and adolescents with acute lymphoblastic leukemia (ALL) treated using the GBTLI-ALL 99..[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número6
... Quality of life in sickle cell disease: assessments by the 36-item Short Form Health Survey Questionnaire and Beck Depression Inventory.. Maria Lucia Ivo 1.[r] ... See full document
1
temas relacionados